A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. (Q54285640)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. |
scientific article |
Statements
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (English)
Diego J Laderach
Lucas D Gentilini
Laura Giribaldi
Victor Cardenas Delgado
Lorena Nugnes
Diego O Croci
Nader Al Nakouzi
Paula Sacca
Gabriel Casas
Osvaldo Mazza
Elba Vazquez
Jeffery L Kutok
Scott J Rodig
MarÃa T Elola
Daniel Compagno
Gabriel A Rabinovich
29 October 2012